ICD-10-CM Billable Code

Q64.7

Other and unspecified congenital malformations of bladder and urethra

Clinical Classification Guidelines

Excludes Type 1

  • congenital prolapse of bladder (mucosa) (Q79.4)

Medical Intelligence & Overview

Congenital malformations of the bladder and urethra are structural abnormalities present at birth that affect these parts of the urinary system. These conditions can vary significantly in severity and impact on health. The ICD-10 code Q64.7 encompasses a range of unspecified and other congenital malformations in this area, highlighting the diversity and complexity of these anomalies.

Causes & Symptoms

Clinical Causes: The exact causes of congenital malformations of the bladder and urethra are often unknown. They are believed to result from a combination of genetic factors and environmental influences during early fetal development. Some potential contributing factors include: - Genetic mutations or inherited conditions - Exposure to certain medications or chemicals during pregnancy - Maternal health issues or infections - Environmental exposures, such as radiation or toxins - Sporadic developmental errors during embryogenesis

Key Symptoms: Symptoms associated with these congenital malformations can widely vary based on the specific type and severity, but may include: - Abnormal urine flow or drainage - Urinary incontinence or leakage - Difficulty urinating or a weak urinary stream - Recurrent urinary tract infections - Abdominal or pelvic pain - Bladder distension or swelling - Visible swelling or abnormalities in the genital area In some cases, infants might not show obvious symptoms initially, with issues becoming apparent later as the child grows.

Diagnostic & Treatment

Diagnosis Path: Diagnosing congenital malformations of the bladder and urethra involves a combination of patient history, physical examinations, and specialized tests. Diagnostic procedures may include: - Ultrasound imaging to visualize the bladder and urethral structure - Voiding cystourethrogram (VCUG), an X-ray test performed during urination to assess how urine flows - Magnetic resonance imaging (MRI) for detailed anatomical assessment - Cystoscopy, a procedure using a thin camera inserted into the bladder - Urodynamic studies to evaluate urinary function These assessments help healthcare providers identify the specific type of malformation and plan appropriate treatment options.

Treatment Protocols: Management of congenital malformations of the bladder and urethra depends on the specific condition and its severity. Approaches often include: - Surgical correction to repair anatomical abnormalities and restore normal function - Antimicrobial treatments to manage or prevent urinary tract infections - Catheterization or other bladder management techniques in cases of functional impairment - Ongoing monitoring to detect and address complications such as recurrent infections or bladder dysfunction - Multidisciplinary care involving urologists, pediatric surgeons, and other specialists Early intervention can be crucial in preventing long-term complications and improving quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q64.7 a billable ICD-10 code?
Yes, Q64.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q64.7?
Clinical documentation must specify the nature of Other and unspecified congenital malformations of bladder and urethra and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

congenital bladder urethra malformations